Home » Blog
CHRTlines
Recent Posts
05/14/2012 Poverty and Health: A Connection We Can't Ignore
04/30/2012 Cardiac Care - A Case Study in Practice Variation
04/16/2012 One Courageous Woman
Browse by Date
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
Tag Cloud
costs poverty aca variation cost use quality health policy research politics health reform policy health insurance acos hmos communication essential benefits reform coverage sgr congress drugs class long term care va employers e-prescribing emrs patient safety medicaid states medicare for-profit nonprofit block grant tanf welfare reform hospice end of life non-profit evidence-based care waste washtenaw county uninsured population health managed care cms access cancer end-of-life care individual mandate ryan proposal obesity pharmaceutical industry r & d comparative effectiveness research evidence based care quality improvement collaborative quality initiatives cqi pharmaceuticals regulations prematurity exchanges heath reform antibiotics overuse geographic variation medical appropriateness health websites imrt radiation therapy medical errors constitutionality courts translate health care economics rationing insurance regulation incentives cardiology pcmh health disparities election british health care system safety net fqhc guidelines radiology pain early childhood electronic medical records physician employment aco dartmouth atlas cover michigan health care coverage insurance preventive care public health
Viewing entries tagged with 'incentives'
A Case in Point: The Tangled Web of Misaligned Incentives and Health Care Costs in the U.S.
In 2007, the COURAGE trial (aka: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation –a mouthful!) results were reported in the New England Journal of Medicine. This study concluded that for those with stable coronary artery disease, the insertion of stents was no better than medication and lifestyle changes at preventing future heart attacks or strokes, nor did it extend life. There were different side effects from each approach but clinically, this trial supports the concept that the choice of treatment ought to be based on patient preferences unless there were unique clinical factors present. The COURAGE trial results were widely publicized and use rates of these procedures have declined overall since then.
Copyright © 2008–2012 Center for Healthcare Research & Transformation
A non-profit partnership between
University of Michigan Health System &
Blue Cross Blue Shield of Michigan